RJA
NXU.U

Raymond James & Associates’s Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi NXU.U Stock Holding History

Raymond James & Associates’s Portfolio NXU.U Stock Details NXU.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-76,245
Closed -$785K – 4360
2021
Q4 		$785K Hold
76,245
– – ﹤0.01% 2782
2021
Q3 		$783K Buy
76,245
+17,695
+30% +$178K ﹤0.01% 2743
2021
Q2 		$593K Buy
58,550
+25
+0% +$252 ﹤0.01% 2964
2021
Q1 		$585K Buy
+58,525
New +$611K ﹤0.01% 2900

Raymond James & Associates's NXU.U Position: Q1 2022 in Review

Raymond James & Associates sold out of Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi (NXU.U) in Q1 2022, closing a stake of 76,245 shares — an estimated $785K sold.

Raymond James & Associates first reported a position in NXU.U in Q1 2021 and held it in 4 quarters. The position peaked at $785K in Q4 2021. 0 funds tracked by Wall St. Rank hold NXU.U as of Q1 2022.

  • Raymond James & Associates reported no remaining Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 76,245 Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi shares in Q1 2022, an estimated $785K.
  • Raymond James & Associates first reported a position in Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi in Q1 2021 and held it in 4 quarters.
  • Raymond James & Associates's Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi position peaked at $785K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.